Hongli Yin

447 total citations
23 papers, 312 citations indexed

About

Hongli Yin is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hongli Yin has authored 23 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hongli Yin's work include Liver Disease Diagnosis and Treatment (5 papers), Protein Degradation and Inhibitors (4 papers) and Ubiquitin and proteasome pathways (4 papers). Hongli Yin is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Protein Degradation and Inhibitors (4 papers) and Ubiquitin and proteasome pathways (4 papers). Hongli Yin collaborates with scholars based in China, United States and Pakistan. Hongli Yin's co-authors include Maoru Li, Ji Ma, Jichun Han, Jing Shang, Owais Ahmad, Bing Wang, Jiajing Li, Yifan Zhang, Yang Deng and Praveen Kumar Kalavagunta and has published in prestigious journals such as International Journal of Molecular Sciences, Cell Reports and Advanced Science.

In The Last Decade

Hongli Yin

19 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongli Yin China	8	111	86	52	32	31	23	312
Og‐Sung Moon South Korea	8	141 1.3×	93 1.1×	69 1.3×	32 1.0×	27 0.9×	10	320
Jing Hao China	9	133 1.2×	81 0.9×	68 1.3×	38 1.2×	78 2.5×	33	453
Yuyang Wang China	7	157 1.4×	43 0.5×	51 1.0×	41 1.3×	25 0.8×	13	347
Mingtai Chen China	10	196 1.8×	107 1.2×	32 0.6×	33 1.0×	37 1.2×	44	426
Xiaodi Zhang China	9	161 1.5×	54 0.6×	51 1.0×	49 1.5×	32 1.0×	16	420
Eleonora Derlindati Italy	13	133 1.2×	41 0.5×	58 1.1×	60 1.9×	31 1.0×	14	403
Shasha Shen China	9	92 0.8×	55 0.6×	53 1.0×	57 1.8×	13 0.4×	20	395
Kai Liang China	6	233 2.1×	100 1.2×	55 1.1×	59 1.8×	23 0.7×	9	439
Noha M. Shawky Egypt	10	136 1.2×	74 0.9×	68 1.3×	50 1.6×	30 1.0×	28	368
Ning Xue China	8	105 0.9×	40 0.5×	42 0.8×	23 0.7×	21 0.7×	26	287

Countries citing papers authored by Hongli Yin

Since Specialization

Citations

This map shows the geographic impact of Hongli Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongli Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongli Yin more than expected).

Fields of papers citing papers by Hongli Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongli Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongli Yin. The network helps show where Hongli Yin may publish in the future.

Co-authorship network of co-authors of Hongli Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Hongli Yin. A scholar is included among the top collaborators of Hongli Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongli Yin. Hongli Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yin, Hongli, et al.. (2025). Bioinspired Prolactin Pulse Release from Responsive Microneedles for Inhibiting Fatty Liver Formation. Advanced Science. 12(36). e08364–e08364.

Yin, Hongli, Tianwei Gu, Fang Da, et al.. (2024). Excessive free fatty acid sensing in pituitary lactotrophs elicits steatotic liver disease by decreasing prolactin levels. Cell Reports. 43(7). 114465–114465. 3 indexed citations

Yin, Hongli, Gen Li, Di Wu, et al.. (2024). METTL14 promotes neuroblastoma formation by inhibiting YWHAH via an m6A-YTHDF1-dependent mechanism. Cell Death Discovery. 10(1). 186–186. 3 indexed citations

Wu, Di, Hongli Yin, Chun Yang, et al.. (2024). The BET PROTAC inhibitor GNE-987 displays anti-tumor effects by targeting super-enhancers regulated gene in osteosarcoma. BMC Cancer. 24(1). 928–928. 4 indexed citations

Yin, Hongli, et al.. (2024). Market Development Analysis of China's New Energy Vehicle Charging Pile. Frontiers in Business Economics and Management. 15(3). 248–252.

Yin, Hongli, et al.. (2024). Gray Correlation Analysis of Energy Consumption, Energy Structure and Economic Growth in China. Frontiers in Business Economics and Management. 15(3). 242–247. 1 indexed citations

Li, Gen, Chenxi Feng, Hongli Yin, et al.. (2024). MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma. BMC Cancer. 24(1). 220–220. 4 indexed citations

Liu, Wenyuan, Hongli Yin, Fang Fang, et al.. (2024). FYB1-targeted modulation of CAPG promotes AML progression. Molecular and Cellular Biochemistry. 480(2). 985–999. 1 indexed citations

Yin, Hongli, et al.. (2024). Changes in metabolic overweight phenotypes over time and risk of nephrolithiasis: a cohort study. BMC Public Health. 24(1). 1898–1898.

10.

Wang, Jianwei, Fang Fang, Yixin Hu, et al.. (2024). Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylation. Cancer Cell International. 24(1). 81–81. 1 indexed citations

11.

Yin, Hongli, et al.. (2023). Efficacy of ranibizumab combined with photocoagulation for diabetic retinopathy: A meta-analysis study. Medicine. 102(31). e34170–e34170. 1 indexed citations

12.

Zheng, Rui, Hongli Yin, Ma Li, et al.. (2023). <i>Mycobacterium tuberculosis</i> Rv2653 Protein Promotes Inflammation Response by Enhancing Glycolysis. Japanese Journal of Infectious Diseases. 76(6). 343–350.

13.

Zhang, Hao, et al.. (2022). Association between serum uric acid/HDL-cholesterol ratio and chronic kidney disease: a cross-sectional study based on a health check-up population. BMJ Open. 12(12). e066243–e066243. 20 indexed citations

14.

Yin, Hongli, et al.. (2022). Science and technology insurance and regional innovation: evidence from provincial panel data in China. Technology Analysis and Strategic Management. 36(4). 746–764. 26 indexed citations

15.

Yin, Hongli, Ji Ma, Jichun Han, Maoru Li, & Jing Shang. (2019). Pharmacokinetic comparison of quercetin, isoquercitrin, and quercetin-3-O-β-D-glucuronide in rats by HPLC-MS. PeerJ. 7. e6665–e6665. 32 indexed citations

16.

Yin, Hongli, et al.. (2019). Time trend of cardiometabolic risk factors over a 10-year period in the office-working population in China. BMJ Open. 9(5). e025915–e025915. 3 indexed citations

17.

Ma, Ji, Hongli Yin, Jichun Han, et al.. (2018). Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model. International Journal of Molecular Sciences. 19(12). 4126–4126. 53 indexed citations

18.

Ma, Ji, Maoru Li, Praveen Kumar Kalavagunta, et al.. (2018). Protective effects of cichoric acid on H2O2-induced oxidative injury in hepatocytes and larval zebrafish models. Biomedicine & Pharmacotherapy. 104. 679–685. 64 indexed citations

19.

Li, Maoru, Ji Ma, Owais Ahmad, et al.. (2018). Lipid-modulate activity of Cichorium glandulosum Boiss. et Huet polysaccharide in nonalcoholic fatty liver disease larval zebrafish model. Journal of Pharmacological Sciences. 138(4). 257–262. 19 indexed citations

20.

Yu, Meihui, et al.. (2016). Hypolipemic Effect of Acidic Polysaccharides from Auricularia auricula on Hyperlipidemia Mice. 37(15). 236. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact